戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 increasingly prescribed for the treatment of eosinophilic esophagitis.
2 without GERD, 18 with achalasia, and 15 with eosinophilic esophagitis.
3  roles of IgE and IgG4 in the development of eosinophilic esophagitis.
4 search contributions in our understanding of eosinophilic esophagitis.
5 nts showed esophageal candidiasis, and 2 had eosinophilic esophagitis.
6 ainst IL-5, in children and adolescents with eosinophilic esophagitis.
7 phil counts in children and adolescents with eosinophilic esophagitis.
8  implicated a role for periostin in allergic eosinophilic esophagitis.
9 ost often encountered and well studied EGID, eosinophilic esophagitis.
10 uld be aware of the clinical presentation of eosinophilic esophagitis.
11 knowledge of the evaluation and treatment of eosinophilic esophagitis.
12 l presentation, diagnosis, and management of eosinophilic esophagitis.
13 e role of food allergy in many patients with eosinophilic esophagitis.
14 ticasone propionate (FP) in the treatment of eosinophilic esophagitis.
15 allowed FP in pediatric patients with active eosinophilic esophagitis.
16 aphy is useful but will miss subtle signs of eosinophilic esophagitis.
17  that specifically homes to the esophagus in eosinophilic esophagitis.
18 tions for the clinical care of patients with eosinophilic esophagitis.
19 antly, IL-5-deficient mice were resistant to eosinophilic esophagitis.
20 reflux management may need to be treated for eosinophilic esophagitis.
21 esonide tablet licensed for the treatment of eosinophilic esophagitis.
22 s, chronic rhinosinusitis, food allergy, and eosinophilic esophagitis.
23 llected in 2020 from US and EU patients with eosinophilic esophagitis.
24 onditions, such as systemic mastocytosis and eosinophilic esophagitis.
25 usceptibility and pathogenesis, most notably eosinophilic esophagitis.
26 leukin-13 signaling, which have key roles in eosinophilic esophagitis.
27  and were currently prescribed treatment for eosinophilic esophagitis.
28 f other eosinophilic disorders, most notably eosinophilic esophagitis.
29 e dysregulated in atopic disorders including eosinophilic esophagitis.
30 ophageal biopsy specimens from patients with eosinophilic esophagitis.
31 ng asthma, chronic rhinosinusitis (CRS), and eosinophilic esophagitis.
32               A subset of these patients has eosinophilic esophagitis, a chronic inflammatory disease
33 n an allergic inflammatory tissue focused on eosinophilic esophagitis, a prototypic, chronic, allergi
34 gic inflammatory diseases, including asthma, eosinophilic esophagitis, allergic rhinitis, and atopic
35 ageal biopsy specimens from 11 subjects with eosinophilic esophagitis and 8 without (controls) were a
36 cosal biopsy specimens from 24 subjects with eosinophilic esophagitis and 9 without (controls).
37 ologies to understand the pathophysiology of eosinophilic esophagitis and development of novel therap
38         EoD gene signatures were shared with eosinophilic esophagitis and eosinophilic gastritis but
39 ffective and novel strategy in patients with eosinophilic esophagitis and esophago-pleural fistula as
40 y, sera were collected from 15 subjects with eosinophilic esophagitis and from 41 without (controls),
41 gion, rs3806932 (G allele protective against eosinophilic esophagitis) and rs2416257 (A allele associ
42 elial dysregulation in asthma, food allergy, eosinophilic esophagitis, and allergic rhinosinusitis.
43  allergic rhinoconjunctivitis, food allergy, eosinophilic esophagitis, and asthma is a widely prevale
44 ogenesis of many diseases, including asthma, eosinophilic esophagitis, and eczema.
45 atric office practice: vitamin D deficiency, eosinophilic esophagitis, and health literacy.
46                        Vitamin D deficiency, eosinophilic esophagitis, and poor health literacy are t
47 icant increase in the literature surrounding eosinophilic esophagitis as more than two-thirds of the
48 mbling immune complexes were found in 2 of 5 eosinophilic esophagitis biopsy specimens based on ultra
49 o be able to properly identify patients with eosinophilic esophagitis but also be informed about the
50 biopsy specimens from 21 of 24 patients with eosinophilic esophagitis, but in none of the specimens f
51 0.6% of centres, ICU admissions by 10.8% and eosinophilic esophagitis by 45.1%.
52                                              Eosinophilic esophagitis can now be treated with biologi
53 gG4 increased only slightly in patients with eosinophilic esophagitis, compared with controls.
54   Esophagectomy samples from 2 patients with eosinophilic esophagitis contained 180 and 300 IgG4 plas
55 herapy) and 20 controls, stored in the Swiss Eosinophilic Esophagitis Database (SEED) and Biobank, we
56 s recapitulated the majority of the clinical Eosinophilic Esophagitis Diagnostic Profile (EDP) on flu
57                              Most reports on eosinophilic esophagitis (EE) are limited to small serie
58                                              Eosinophilic esophagitis (EE) is an emerging disease ass
59                                              Eosinophilic esophagitis (EE) is an emerging disorder wi
60                                              Eosinophilic esophagitis (EE) is an increasingly recogni
61                                              Eosinophilic esophagitis (EE) is an isolated, eosinophil
62                                              Eosinophilic esophagitis (EE) is frequently associated w
63 previously proposed that the pathogenesis of eosinophilic esophagitis (EE) is mediated by an IL-13-dr
64 at these patients had a "new" disease termed eosinophilic esophagitis (EE).
65  gastrointestinal tract induces experimental eosinophilic esophagitis (EE).
66                          After adjusting for Eosinophilic Esophagitis Endoscopic Reference Score and
67                                              Eosinophilic esophagitis (EoE) afflicts both children an
68                        Current treatments of eosinophilic esophagitis (EoE) aim to eliminate esophage
69 ate (FP) and dose reduction in patients with eosinophilic esophagitis (EoE) and analyzed esophageal t
70 ely mimic the Th2 and inflammatory milieu of eosinophilic esophagitis (EoE) and assessed alterations
71                       An association between eosinophilic esophagitis (EoE) and celiac disease (CD) h
72                                Patients with eosinophilic esophagitis (EoE) and extremely high esopha
73 us removal occur frequently in patients with eosinophilic esophagitis (EoE) and harbor a risk for sev
74       EGIDs are traditionally separated into eosinophilic esophagitis (EoE) and non-EoE EGIDs.
75 responsive, representing 2 entities known as eosinophilic esophagitis (EoE) and PPI-responsive esopha
76  for a long time an option for patients with eosinophilic esophagitis (EoE) and remains the only ther
77 ruments are needed to assess the activity of eosinophilic esophagitis (EoE) and to provide end points
78 l biopsy tissue from individuals with active eosinophilic esophagitis (EoE) and were present at marke
79                                              Eosinophilic esophagitis (EoE) can progress to fibrosten
80              Fibrostenosis, the most serious eosinophilic esophagitis (EoE) complication, is mediated
81             Disease activity and severity of eosinophilic esophagitis (EoE) dictate therapeutic optio
82                                              Eosinophilic esophagitis (EoE) exhibits esophageal dysfu
83 of interleukin (IL)-5 in the pathogenesis of eosinophilic esophagitis (EoE) has been established in a
84                         A high prevalence of eosinophilic esophagitis (EoE) has been preliminarily re
85                                              Eosinophilic esophagitis (EoE) has emerged over the past
86 expression and translation, in patients with eosinophilic esophagitis (EoE) has not been explored.
87                                    Thus far, eosinophilic esophagitis (EoE) has received the most foc
88             Links between food allergens and eosinophilic esophagitis (EoE) have been established, bu
89 ints used to determine treatment efficacy in eosinophilic esophagitis (EoE) have evolved over time.
90 with subepithelial fibrosis in subjects with eosinophilic esophagitis (EoE) have not been delineated.
91                                              Eosinophilic esophagitis (EoE) incidence and prevalence
92               Topical steroid treatments for eosinophilic esophagitis (EoE) include swallowed flutica
93                                              Eosinophilic esophagitis (EoE) involves a chronic immune
94                                              Eosinophilic esophagitis (EoE) is a chronic allergic dis
95                                              Eosinophilic esophagitis (EoE) is a chronic allergic dis
96                                              Eosinophilic esophagitis (EoE) is a chronic allergic dis
97                                              Eosinophilic esophagitis (EoE) is a chronic allergic inf
98                                              Eosinophilic esophagitis (EoE) is a chronic and increasi
99                                              Eosinophilic esophagitis (EoE) is a chronic antigen-driv
100                                              Eosinophilic esophagitis (EoE) is a chronic antigen-medi
101                                              Eosinophilic esophagitis (EoE) is a chronic antigen-medi
102                                              Eosinophilic esophagitis (EoE) is a chronic disease char
103                                              Eosinophilic Esophagitis (EoE) is a chronic food allergy
104                                              Eosinophilic esophagitis (EoE) is a chronic immune media
105                                              Eosinophilic esophagitis (EoE) is a chronic immune-media
106                                              Eosinophilic esophagitis (EoE) is a chronic immune/antig
107                                              Eosinophilic esophagitis (EoE) is a chronic inflammatory
108                                              Eosinophilic esophagitis (EoE) is a chronic inflammatory
109                                              Eosinophilic esophagitis (EoE) is a chronic inflammatory
110                                              Eosinophilic esophagitis (EoE) is a chronic inflammatory
111                                              Eosinophilic esophagitis (EoE) is a chronic inflammatory
112                                              Eosinophilic esophagitis (EoE) is a chronic inflammatory
113                                              Eosinophilic esophagitis (EoE) is a chronic T(H)2 disord
114                                              Eosinophilic esophagitis (EoE) is a chronic T(H)2-associ
115                                              Eosinophilic esophagitis (EoE) is a chronic TH2 inflamma
116                                              Eosinophilic esophagitis (EoE) is a chronic type 2 aller
117                                              Eosinophilic esophagitis (EoE) is a chronic Type 2 infla
118                                              Eosinophilic esophagitis (EoE) is a chronic, esophageal,
119                                              Eosinophilic esophagitis (EoE) is a chronic, food antige
120                                              Eosinophilic esophagitis (EoE) is a chronic, food-driven
121                                              Eosinophilic esophagitis (EoE) is a chronic, immune/anti
122                                              Eosinophilic esophagitis (EoE) is a chronic, inflammator
123                                              Eosinophilic esophagitis (EoE) is a chronic, Th2-type in
124                                              Eosinophilic esophagitis (EoE) is a clinicopathologic en
125                                              Eosinophilic esophagitis (EoE) is a clinicopathological
126                                              Eosinophilic esophagitis (EoE) is a condition characteri
127                                              Eosinophilic esophagitis (EoE) is a disorder characteriz
128                                              Eosinophilic esophagitis (EoE) is a food allergen driven
129                                              Eosinophilic esophagitis (EoE) is a food allergy-associa
130                                              Eosinophilic esophagitis (EoE) is a histologically "patc
131                                              Eosinophilic esophagitis (EoE) is a new disease.
132                     Like many rare diseases, eosinophilic esophagitis (EoE) is a poorly understood di
133                                              Eosinophilic esophagitis (EoE) is a rapidly emerging, ch
134                                              Eosinophilic esophagitis (EoE) is a rare atopic disorder
135                                              Eosinophilic esophagitis (EoE) is a recently described d
136                                              Eosinophilic esophagitis (EoE) is a recently recognized
137                                              Eosinophilic esophagitis (EoE) is a relatively new disea
138                                              Eosinophilic esophagitis (EoE) is a severe inflammatory
139                                              Eosinophilic esophagitis (EoE) is a T-cell-mediated dise
140                                              Eosinophilic esophagitis (EoE) is a Th2 cytokine-associa
141                                              Eosinophilic esophagitis (EoE) is an allergen-mediated i
142                                              Eosinophilic esophagitis (EoE) is an allergic disease of
143                                              Eosinophilic esophagitis (EoE) is an allergic disease th
144                                              Eosinophilic esophagitis (EoE) is an allergic disorder c
145                                              Eosinophilic esophagitis (EoE) is an allergic disorder c
146                                              Eosinophilic esophagitis (EoE) is an allergic inflammato
147                                              Eosinophilic esophagitis (EoE) is an antigen-mediated eo
148                                              Eosinophilic esophagitis (EoE) is an atopic disease char
149                                              Eosinophilic esophagitis (EoE) is an emerging chronic in
150                                              Eosinophilic esophagitis (EoE) is an emerging chronic in
151                                              Eosinophilic esophagitis (EoE) is an emerging tissue-spe
152                                              Eosinophilic esophagitis (EoE) is an emerging, chronic,
153                                              Eosinophilic esophagitis (EoE) is an eosinophil-rich, T(
154                                              Eosinophilic esophagitis (EoE) is an esophageal disorder
155                                              Eosinophilic esophagitis (EoE) is an esophageal inflamma
156                                              Eosinophilic esophagitis (EoE) is an immunoinflammatory
157                                              Eosinophilic esophagitis (EoE) is an increasingly common
158                                              Eosinophilic esophagitis (EoE) is an inflammatory disord
159                                     Although eosinophilic esophagitis (EoE) is associated with certai
160                                              Eosinophilic esophagitis (EoE) is caused by immunologic
161                             The pathology of eosinophilic esophagitis (EoE) is characterized by eosin
162                                              Eosinophilic esophagitis (EoE) is characterized by persi
163                         Treatment failure in eosinophilic esophagitis (EoE) is common.
164                                              Eosinophilic esophagitis (EoE) is diagnosed and monitore
165       A 6-food elimination diet in pediatric eosinophilic esophagitis (EoE) is difficult to implement
166                             The incidence of eosinophilic esophagitis (EoE) is greater in male than f
167                            The prevalence of Eosinophilic esophagitis (EoE) is increasing, a severe c
168 ACKGROUND & AIMS: Pharmacologic treatment of eosinophilic esophagitis (EoE) is limited to off-label u
169                   Pharmacologic treatment of eosinophilic esophagitis (EoE) is limited to off-label u
170                                              Eosinophilic esophagitis (EoE) is of increasing prevalen
171                                              Eosinophilic esophagitis (EoE) is often associated with
172 nd histopathologic and molecular features of eosinophilic esophagitis (EoE) is unclear.
173 g studies have observed an increased risk of eosinophilic esophagitis (EoE) mostly among first-degree
174                                              Eosinophilic esophagitis (EoE) now represents a commonly
175                                Patients with eosinophilic esophagitis (EoE) often become dysphagic fr
176           With the increasing recognition of eosinophilic esophagitis (EoE) over the past two decades
177                     Diagnostic evaluation of eosinophilic esophagitis (EoE) remains difficult, partic
178 nality and diagnosis and/or recrudescence of eosinophilic esophagitis (EoE) remains unclear, with som
179 ps most likely to trigger allergies achieves eosinophilic esophagitis (EoE) remission in children, da
180               BACKGROUND & AIMS: Adults with eosinophilic esophagitis (EoE) typically present with dy
181 he mechanical properties of the esophagus in eosinophilic esophagitis (EoE) using the functional lumi
182                                              Eosinophilic esophagitis (EoE) was historically distingu
183                                              Eosinophilic esophagitis (EoE) was recognized as its own
184 toms and histological findings suggestive of eosinophilic esophagitis (EoE) who achieve complete remi
185                                              Eosinophilic esophagitis (EoE), a chronic allergic infla
186 tain homeostasis, and disruption can lead to eosinophilic esophagitis (EoE), a chronic inflammatory d
187 ng eosinophilic tissue inflammation, such as eosinophilic esophagitis (EoE), a chronic inflammatory d
188                                              Eosinophilic esophagitis (EoE), a food antigen-mediated
189 senger RNA in the esophagus of patients with eosinophilic esophagitis (EoE), a recently recognized al
190 ve been recognized as a primary treatment of eosinophilic esophagitis (EoE), an allergic inflammatory
191       The molecular and cellular etiology of eosinophilic esophagitis (EoE), an emerging tissue-speci
192 L-22, and IL-23) of patients with achalasia, eosinophilic esophagitis (EoE), and gastroesophageal ref
193  advances in the pathologic understanding of eosinophilic esophagitis (EoE), as of yet, no single age
194 rs in the rapid increase in the incidence of eosinophilic esophagitis (EoE), but potential exposures
195                             In patients with eosinophilic esophagitis (EoE), eosinophils accumulate a
196 ated with pathological conditions, including eosinophilic esophagitis (EoE), in which basal progenito
197 orrelate with tissue pathology during active eosinophilic esophagitis (EoE), providing additional evi
198 ical, endoscopic, and histologic features of eosinophilic esophagitis (EoE), review the current diagn
199 plays an important role in the management of eosinophilic esophagitis (EoE), since it is involved in
200 vidence of epithelial barrier dysfunction in eosinophilic esophagitis (EoE), the lipid composition of
201 iagnosis of an emerging form of esophagitis, eosinophilic esophagitis (EoE), which is currently diagn
202 ntions have been used to treat patients with eosinophilic esophagitis (EoE), yielding varied results.
203                                      Chronic eosinophilic esophagitis (EoE)-associated inflammation c
204 ce to endoscopic procedures in patients with eosinophilic esophagitis (EoE).
205  gastroesophageal reflux disease (GERD), and eosinophilic esophagitis (EoE).
206 ictures is a major concern for patients with eosinophilic esophagitis (EoE).
207 al lamina propria is a known complication of eosinophilic esophagitis (EoE).
208 iscous topical corticosteroid treatments for eosinophilic esophagitis (EoE).
209 y of life (HRQOL) of pediatric patients with Eosinophilic Esophagitis (EoE).
210 steroids (TS) is used to treat children with eosinophilic esophagitis (EoE).
211 hinosinusitis with nasal polyps (CRSwNP) and eosinophilic esophagitis (EoE).
212 ure are major comorbidities in patients with eosinophilic esophagitis (EoE).
213 g gastroesophageal reflux disease (GERD) and eosinophilic esophagitis (EoE).
214 using on a tissue-specific allergic disease, eosinophilic esophagitis (EoE).
215  factor in many allergic diseases, including eosinophilic esophagitis (EoE).
216 ds are recommended as first-line therapy for eosinophilic esophagitis (EoE).
217 f empiric elimination diets in patients with eosinophilic esophagitis (EoE).
218  elimination from the diets of patients with eosinophilic esophagitis (EoE).
219       Dysphagia is the main symptom of adult eosinophilic esophagitis (EoE).
220 be used to estimate the biologic activity of eosinophilic esophagitis (EoE).
221 e of type 2 cytokines in the pathogenesis of eosinophilic esophagitis (EoE); however, heterogeneity i
222 contribute to the clinical manifestations of eosinophilic esophagitis (EoE); however, the molecular p
223                                              Eosinophilic esophagitis experts were surveyed to estima
224 in asthma, rhinitis, chronic rhinosinusitis, eosinophilic esophagitis, food allergy, and atopic derma
225 verlap between symptoms of GERD and those of eosinophilic esophagitis, functional dyspepsia, and gast
226 ind, placebo-controlled trial of adults with eosinophilic esophagitis given an antibody against IgE (
227 tes of esophageal tissues from patients with eosinophilic esophagitis had a 45-fold increase in IgG4
228                                Subjects with eosinophilic esophagitis had increased serum levels of I
229 ts were aged >= 12 years with a diagnosis of eosinophilic esophagitis, had an esophageal count of >=
230                                              Eosinophilic esophagitis has been reported as a complica
231                             Understanding of eosinophilic esophagitis has evolved to a point at which
232                                 Treatment of eosinophilic esophagitis has progressed from elemental f
233                                Patients with eosinophilic esophagitis have increased numbers of mucos
234 ses marked by type 2 inflammation, including eosinophilic esophagitis in adults and adolescents.
235 ing on the pathophysiology, and treatment of eosinophilic esophagitis in both children and adults.
236                              The etiology of eosinophilic esophagitis in children is reported to be a
237 a useful large animal model for the study of eosinophilic esophagitis in humans.
238 se in the number of publications relating to eosinophilic esophagitis in terms of case reports, cohor
239 ile the most commonly involved foods causing eosinophilic esophagitis include milk, eggs, nuts, beef,
240 diography may be useful for obvious signs of eosinophilic esophagitis including rings and strictures.
241 ied cytokines relevant toward development of eosinophilic esophagitis, including interleukin-5 and in
242 al or intragastric allergen does not promote eosinophilic esophagitis, indicating that hypersensitivi
243                          The pathogenesis of eosinophilic esophagitis involves environmental and gene
244                                              Eosinophilic esophagitis is a chronic allergic disease w
245                                              Eosinophilic esophagitis is a chronic, immune-mediated i
246                                              Eosinophilic esophagitis is a clinicopathologic disease
247                                   Therefore, eosinophilic esophagitis is a disease with unique featur
248                                              Eosinophilic esophagitis is a disorder increasing in fre
249                                              Eosinophilic esophagitis is a new disease commonly confu
250                                              Eosinophilic esophagitis is a recently recognized but ex
251                                              Eosinophilic esophagitis is an allergy-based disorder.
252                                              Eosinophilic esophagitis is an emerging disease that is
253                                              Eosinophilic esophagitis is an increasingly recognized d
254                                              Eosinophilic esophagitis is an increasingly recognized p
255                                              Eosinophilic esophagitis is an isolated, eosinophilic in
256                                              Eosinophilic esophagitis is being diagnosed in both chil
257                                 By contrast, eosinophilic esophagitis is characterized by low levels
258        The role of specific foods in causing eosinophilic esophagitis is elucidated by several studie
259 to specific foods, indicate that, in adults, eosinophilic esophagitis is IgG4-associated, and not an
260 ause of different treatments, recognition of eosinophilic esophagitis is important.
261 mechanism of persisting dysphagia in treated eosinophilic esophagitis is not apparent on high-quality
262          Previously perceived as an anomaly, eosinophilic esophagitis is now frequently diagnosed by
263                                 Diagnosis of eosinophilic esophagitis is suggested by food impaction
264                                     Although eosinophilic esophagitis is treatable, it is thought to
265                                              Eosinophilic esophagitis is usually triggered by foods,
266                                              Eosinophilic esophagitis-like esophageal inflammation wa
267 studies support the role of the allergist in eosinophilic esophagitis management, especially for food
268 ely to be important for successful long-term eosinophilic esophagitis management.
269                                              Eosinophilic esophagitis may affect individuals at any a
270 ive instrument development phase, the PedsQL Eosinophilic Esophagitis Module is now undergoing multis
271 hods, the content validity of the new PedsQL Eosinophilic Esophagitis Module items was supported in t
272 Pediatric Quality of Life Inventory (PedsQL) Eosinophilic Esophagitis Module.
273         Omalizumab did not alter symptoms of eosinophilic esophagitis or eosinophil counts in biopsy
274 trial, omalizumab did not reduce symptoms of eosinophilic esophagitis or tissue eosinophil counts com
275  5: Patients with known Barrett's esophagus, eosinophilic esophagitis, or idiopathic pulmonary fibros
276 asophils, and interleukin-9 are important in eosinophilic esophagitis pathogenesis.
277 wth factor beta production and signaling, to eosinophilic esophagitis pathophysiology.
278                                              Eosinophilic esophagitis patients were stratified based
279 at in patients without GERD or patients with eosinophilic esophagitis; patients with GERD had low MI
280  (1) anaphylactic sensitivity to peanut, (2) eosinophilic esophagitis related to cow's milk, and (3)
281 hylaxis, epinephrine use, and 2 diagnoses of eosinophilic esophagitis related to DC.
282                                   Studies on eosinophilic esophagitis show a relationship to connecti
283 ented the unique epidemiologic parameters of eosinophilic esophagitis, some of its natural history, a
284 presentation, pathogenesis, and treatment of eosinophilic esophagitis, some of which will be summariz
285    During the last 5 years, the emergence of eosinophilic esophagitis stimulated many case series; th
286                          Among patients with eosinophilic esophagitis, subcutaneous dupilumab adminis
287                              We also discuss eosinophilic esophagitis subtypes, factors associated wi
288 ergic rhinitis, allergic conjunctivitis, and eosinophilic esophagitis), suggesting both cutaneous and
289                                The Pediatric Eosinophilic Esophagitis Symptom Score (PEESS v2.0) meas
290 gitis or nonerosive but pH-abnormal GERD) or eosinophilic esophagitis than in patients without GERD o
291 ificantly higher percentage of children with eosinophilic esophagitis than placebo.
292 of this EG transcriptome overlapped with the eosinophilic esophagitis transcriptome.
293 ric transcriptome markedly distinct from the eosinophilic esophagitis transcriptome.
294  in oral Ag-induced esophageal eosinophilia, eosinophilic esophagitis was induced by allergen exposur
295 bservational study was continued, a study of eosinophilic esophagitis was initiated, and new therapeu
296  patients with eosinophilic skin diseases or eosinophilic esophagitis were used for in vivo analyses.
297 ve, non-glucocorticoid-treated patients with eosinophilic esophagitis who had 2 consecutive endoscopi
298 ixed esophageal tissues from 2 patients with eosinophilic esophagitis who underwent esophagectomy and
299 s review covers the role of the allergist in eosinophilic esophagitis with a focus on the literature
300 ffective in inducing histologic remission in eosinophilic esophagitis, with a more pronounced effect

 
Page Top